CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


plasma from convalescent patients with COVID-19Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug1483 Methylene Blue 5 MG/ML Wiki 1.00
drug2814 exchange blood transfusion from normal donor Wiki 1.00
drug1606 Nitric Oxide Gas Wiki 0.58

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19

The aim of this project is to introduce way for treatment of patients with severe COVID-19 disease with respiratory complications.

NCT04376788 COVID-19 Biological: exchange blood transfusion from normal donor Biological: plasma from convalescent patients with COVID-19 Drug: Methylene Blue 5 MG/ML

Primary Outcomes

Description: improvement of general condition of the patients as the ventilator parameters and serum level of ferritin , D dimer, CBC, oxygen level in blood and patient o2 saturation

Measure: improvement of condition

Time: three to five days days

Secondary Outcomes

Description: change in the liver , kidney function and change in ferritin level with normal D Dimer

Measure: change in organs function with PFS and OS

Time: 0ne month


No related HPO nodes (Using clinical trials)